DialysisPPO, a
Pennsylvania Corporation providing rate containment
solutions to the condition plan market, has filed a pro tem
palpable pertinence with the United States Transparent and
Trademark Thing (USPTO) covering its business method that
enables health plans to significantly reduce their exposure
to the high cost of dialysis services while simultaneously
improving the benefits to plan participants.

Impotencia sexual masculina

Plan members diagnosed with End-Juncture Renal Disease (”ESRD”)
must either receive a kidney transplant or undergo a dependable
course of life-sustaining dialysis treatments. Ample to the
gravity of this disease, ESRD is the merely diagnosis in all
of American healthcare that entitles a person to Medicare
coverage, regardless of their ripen. Unfortunately for well-being
plans, Medicare does not become the primary payer in return
generally three years, leaving health plans responsible
for treatments that can tariff in plethora of $600,000 per
person annually. Our business method patent enables health
plans to crop their annual costs by as much as 90%, while
at the same dated improving the level of benefits suited for chart
members suffering from ESRD.

DialysisPPO